Cargando…
Correction: Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly
Autores principales: | Lu, Haohao, Zheng, Chuansheng, Xiong, Bin, Xia, Xiangwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890705/ https://www.ncbi.nlm.nih.gov/pubmed/36721271 http://dx.doi.org/10.1186/s12876-022-02635-w |
Ejemplares similares
-
Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly
por: Lu, Haohao, et al.
Publicado: (2022) -
Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension
por: Ozturk, Omer, et al.
Publicado: (2016) -
Quantitative splenic embolization possible: application of 8Spheres conformal microspheres in partial splenic embolization (PSE)
por: Lu, Haohao, et al.
Publicado: (2021) -
Splenectomy versus Partial Splenic Embolization for Massive Splenomegaly Secondary to Hepatitis B-Related Liver Cirrhosis: A Case-Control Study
por: Jiao, Shoufei, et al.
Publicado: (2016) -
Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective study
por: Lu, Haohao, et al.
Publicado: (2023)